Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.

Meyer AR, Engevik AC, Willet SG, Williams JA, Zou Y, Massion PP, Mills JC, Choi E, Goldenring JR.

Cell Mol Gastroenterol Hepatol. 2019 May 6. pii: S2352-345X(19)30060-8. doi: 10.1016/j.jcmgh.2019.04.015. [Epub ahead of print]

2.

Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.

Wada T, Ishimoto T, Seishima R, Tsuchihashi K, Yoshikawa M, Oshima H, Oshima M, Masuko T, Wright NA, Furuhashi S, Hirashima K, Baba H, Kitagawa Y, Saya H, Nagano O.

Cancer Sci. 2013 Oct;104(10):1323-9. doi: 10.1111/cas.12236. Epub 2013 Aug 12.

3.

Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.

Petersen CP, Weis VG, Nam KT, Sousa JF, Fingleton B, Goldenring JR.

Gastroenterology. 2014 Jun;146(7):1727-38.e8. doi: 10.1053/j.gastro.2014.02.007. Epub 2014 Feb 15.

4.

Maturity and age influence chief cell ability to transdifferentiate into metaplasia.

Weis VG, Petersen CP, Weis JA, Meyer AR, Choi E, Mills JC, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2017 Jan 1;312(1):G67-G76. doi: 10.1152/ajpgi.00326.2016. Epub 2016 Nov 23.

5.

Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.

Nam KT, O'Neal RL, Coffey RJ, Finke PE, Barker N, Goldenring JR.

Gut. 2012 Dec;61(12):1678-85. doi: 10.1136/gutjnl-2011-301193. Epub 2011 Dec 23.

6.

Injury, repair, inflammation and metaplasia in the stomach.

Meyer AR, Goldenring JR.

J Physiol. 2018 Sep;596(17):3861-3867. doi: 10.1113/JP275512. Epub 2018 Mar 24.

PMID:
29427515
7.

Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.

Choi E, Hendley AM, Bailey JM, Leach SD, Goldenring JR.

Gastroenterology. 2016 Apr;150(4):918-30.e13. doi: 10.1053/j.gastro.2015.11.049. Epub 2015 Dec 8.

8.

Mature gastric chief cells are not required for the development of metaplasia.

Kinoshita H, Hayakawa Y, Niu Z, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Hirata Y, Wang TC, Koike K.

Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G583-G596. doi: 10.1152/ajpgi.00351.2017. Epub 2018 Jan 18.

9.

Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.

Radyk MD, Burclaff J, Willet SG, Mills JC.

Gastroenterology. 2018 Mar;154(4):839-843.e2. doi: 10.1053/j.gastro.2017.11.278. Epub 2017 Dec 14.

10.

Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.

Weis VG, Petersen CP, Mills JC, Tuma PL, Whitehead RH, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G777-92. doi: 10.1152/ajpgi.00169.2014. Epub 2014 Sep 4.

11.

A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.

Nozaki K, Ogawa M, Williams JA, Lafleur BJ, Ng V, Drapkin RI, Mills JC, Konieczny SF, Nomura S, Goldenring JR.

Gastroenterology. 2008 Feb;134(2):511-22. doi: 10.1053/j.gastro.2007.11.058. Epub 2007 Dec 4.

12.

Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Weis VG, Sousa JF, LaFleur BJ, Nam KT, Weis JA, Finke PE, Ameen NA, Fox JG, Goldenring JR.

Gut. 2013 Sep;62(9):1270-9. doi: 10.1136/gutjnl-2012-302401. Epub 2012 Jul 7.

13.

Altered gastric chief cell lineage differentiation in histamine-deficient mice.

Nozaki K, Weis V, Wang TC, Falus A, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1211-20. doi: 10.1152/ajpgi.90643.2008. Epub 2009 Apr 9.

14.

Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.

Nam KT, Varro A, Coffey RJ, Goldenring JR.

Gastroenterology. 2007 May;132(5):1804-19. Epub 2007 Mar 24.

PMID:
17484876
15.

Mature chief cells are cryptic progenitors for metaplasia in the stomach.

Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE, Romero-Gallo J, Shi G, Mills JC, Peek RM Jr, Konieczny SF, Goldenring JR.

Gastroenterology. 2010 Dec;139(6):2028-2037.e9. doi: 10.1053/j.gastro.2010.09.005. Epub 2010 Sep 18.

16.

Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma.

Nagane M, Kanai E, Shibata Y, Shimizu T, Yoshioka C, Maruo T, Yamashita T.

PLoS One. 2018 Apr 12;13(4):e0195151. doi: 10.1371/journal.pone.0195151. eCollection 2018.

17.

Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Nam KT, Lee HJ, Mok H, Romero-Gallo J, Crowe JE Jr, Peek RM Jr, Goldenring JR.

Gastroenterology. 2009 Apr;136(4):1288-96. doi: 10.1053/j.gastro.2008.12.037. Epub 2008 Dec 13.

18.

Metaplasia in the Stomach Arises From Gastric Chief Cells.

Mills JC, Goldenring JR.

Cell Mol Gastroenterol Hepatol. 2017 Mar 23;4(1):85-88. doi: 10.1016/j.jcmgh.2017.03.006. eCollection 2017 Jul.

19.

Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.

Ogawa M, Nomura S, Varro A, Wang TC, Goldenring JR.

Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G793-804. Epub 2005 Nov 23.

20.

Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.

Miyoshi S, Tsugawa H, Matsuzaki J, Hirata K, Mori H, Saya H, Kanai T, Suzuki H.

Anticancer Res. 2018 Nov;38(11):6163-6170. doi: 10.21873/anticanres.12969.

PMID:
30396933

Supplemental Content

Support Center